Soft chemotherapy is very effective in older patients when added to targeted treatment in an aggressive breast cancer subtype

(European Organisation for Research and Treatment of Cancer) A trial published todayin The Lancet Oncology, shows that, in older patients with HER2 positive metastatic breast cancer (an aggressive breast cancer subtype where the cancer has spread to other parts of the body), a combination of a 'soft' chemotherapy with antiHER2 therapy is highly active and has low toxicity, important in a frail population.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2EdulIt